Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies.

Navid Shomali, Marwah Suliman Maashi, Behzad Baradaran, Amin Daei Sorkhabi, Aila Sarkesh, Hamed Mohammadi, Maryam Hemmatzadeh, Faroogh Marofi, Siamak Sandoghchian Shotorbani, Mostafa Jarahian

Frontiers in immunology 2022

filter terms:

It has been well established that the etiopathogenesis of diverse autoimmune diseases is rooted in the autoreactive immune cells' excessively proliferative state and impaired apoptotic machinery. Survivin is an anti-apoptotic and mitotic factor that has sparked a considerable research interest in this field. Survivin overexpression has been shown to contribute significantly to the development of autoimmune diseases via autoreactive immune cell overproliferation and apoptotic dysregulation. Several microRNAs (miRNAs/miRs) have been discovered to be involved in survivin regulation, rendering the survivin-miRNA axis a perspective target for autoimmune disease therapy. In this review, we discuss the role of survivin as an immune regulator and a highly implicated protein in the pathogenesis of autoimmune diseases, the significance of survivin-targeting miRNAs in autoimmunity, and the feasibility of targeting the survivin-miRNA axis as a promising therapeutic option for autoimmune diseases. Copyright © 2022 Shomali, Suliman Maashi, Baradaran, Daei Sorkhabi, Sarkesh, Mohammadi, Hemmatzadeh, Marofi, Sandoghchian Shotorbani and Jarahian.

Citation

Navid Shomali, Marwah Suliman Maashi, Behzad Baradaran, Amin Daei Sorkhabi, Aila Sarkesh, Hamed Mohammadi, Maryam Hemmatzadeh, Faroogh Marofi, Siamak Sandoghchian Shotorbani, Mostafa Jarahian. Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies. Frontiers in immunology. 2022;13:839945